Introduction N-linked glycosylation sites and their role in viral immune escape N-linked glycosylation sites are also referred to as sequons. For an asparagine (N) to be glycosylated, it requires the context of the amino acid pattern N-X- [S or T] (Marshall, 1974) , where X can be any amino acid, followed by a Serine (S) or Threonine (T). A sequon will not be glycosylated if it contains or is followed by a Proline (Gavel and von Heijne, 1990) , and glycosylation may be inhibited by certain combinations of N-X-S or when followed by specific amino acids (Kasturi et al., 1995; Mellquist et al., 1998; ShakinEshleman et al., 1996) .
Alteration of a glycosylation site can have dramatic consequences for a virus. It can impact protein folding (Hebert et al., 1997; Land and Braakman, 2001; Slater-Handshy et al., 2004) and conformation (Meunier et al., 1999) and affect distant parts of a protein through masking or conformational changes. Although gain of a carbohydrate can sterically mask epitopes, the loss of one could result in tighter packing of glycoprotein regions involved in neutralization epitopes, reduce accessibility, and so also facilitate immune escape (Ye et al., 2000) . The loss of sequons can even impact immunogenicity of noncovalently associated proteins, for example a change in sequons in the human immunodeficiency virus type 1 (HIV-1) transmembrane envelope (Env) protein gp41 induces conformational changes in the associated Env gp120 surface protein that dramatically diminish the binding of many gp120-specific antibodies . Altered patterns of glycosylation in viral proteins can also contribute to escape from T cell responses (Botarelli et al., 1991; Ferris et al., 1999; Selby et al., 1999) and influence receptor binding and phenotypic properties of viruses (Kaverin et al., 2002; Koito et al., 1995; Matrosovich et al., 1999; Ogert et al., 2001; Pollakis et al., 2001) .
Influenza, glycosylation, and antigenic drift Some of the earliest studies on the biological and immunological consequences of glycosylation site variation were conducted in influenza proteins (Alexander and Elder, 1984) . The number of sequons in the heavily glycosylated influenza A hemagglutinin 1 (HA1) of the pandemic H3 virus has increased from 6 to 10 since it entered the human population in 1968 (Skehel and Wiley, 2000) , and the increase is assumed to make HA1 generally more refractive to antibodies. For example, the amino acids around the N-linked glycosylations site at position N165 of HA stopped participating in antigenic drift (Skehel and Wiley, 2000; Wiley and Skehel, 1987) .
HIV Env and glycosylation site variation
HIV-1 is highly variable, and variants are grouped through phylogenetic analysis into major clades or subtypes (A-K). Recombinant forms of HIV are very common (Robertson et al., 2000) , and when a lineage based on recombination between two subtypes becomes an important epidemic lineage, it is called a circulating recombinant form (CRF). HIV-1 varies dramatically within a clade and within infected individuals. HIV Env gp120 is among the most heavily glycosylated proteins in nature (Myers et al., 1992) , far more heavily glycosylated than envelopes of other retroviruses of similar size (e.g., HTLV-1, MuLV) (Polonoff et al., 1982) . The influence of sequon variation on HIV antibody recognition and viral phenotype has been studied in the context of HIV and SIV Env proteins (Chackerian et al., 1997; Cheng-Mayer et al., 1999; Losman et al., 2001; Ly and Stamatatos, 2000; Malenbaum et al., 2000; Matthews et al., 1987; Ratner 1992; Ye et al., 2000) . Sigvard Olofsson and colleagues first showed that glycosylation of gp120 could change exposure of neutralizing antibody epitopes (Bolmstedt et al., 1996) . In the HIV-1 CRF01, the absence of a sequon near the base of the V3 loop, an important antigenic doman of Env gp120, was correlated with rapid amino acid substitutions and positive selection (Kalish et al., 2002) , suggesting a similar situation to the influenza A HA protein, where a glycosylation site may provide regional protection from antibodies (Skehel and Wiley 2000) . The number of Env sequons in both HIV and SIV infections varies extensively within infected individuals (Overbaugh and Rudensey, 1992; Wolinsky et al., 1992) , and this variation constitutes a mechanism of immune escape during the course of an HIV or SIV infection (Cheng-Mayer et al., 1999; Davis et al., 1990; Simmonds et al., 1991) .
A heavily glycosylated face of the 3D structure of Env gp120 has been called the immunologically silent face (Moore and Sodroski, 1996) . Generally carbohydrate moieties appear as self to the immune system, so this face reduces the antigenicity of a large region on the gp120 surface. Glycosylation of variable loops restricts access to conserved receptor binding sites and limits their exposure to the immune system (Wyatt and Sodroski, 1998) , and HIV Env has been described as having a glycan shield (Wei et al., 2003) .
A recent survey of the global collection of HIV-1 Env gp120 surface protein M group sequences in the Los Alamos HIV database showed that gp120 varied in length between 484 and 543 amino acids . The number of potential sequons in gp120 ranges between 18 and 33 with a median of 25 (Figure 1 ) (this range is often ignored and HIV is frequently reported to have 25 N-linked glycosylation sites). The dramatic variation in number of sequons partly results from gp120 length variation frequently involving insertions and deletions of potential glycosylation sites inside HIV hypervariable domains, however, evolutionary propensities in base substitution patterns in HIV may also contribute to the rapid flux in numbers of sequons in gp120 (Bosch et al., 1994; Kuiken et al., 1999) .
Not all potential glycosylation sites on a given HIV-1 Env protein are fully occupied (Zhu et al., 2000) . For example, NNTT is a common pattern among HIV sequences, and steric occlusion may prevent carbohydrate addition to both asparagines, and the protein context of sequons does not always favor glycosylation (Kasturi et al., 1995; Mellquist et al., 1998; Shakin-Eshleman et al., 1996) .
Glycosylation and hepatitis C Env diversity
Hepatitis C virus (HCV) belongs to the Hepacivirus genus in the Flaviviridae family (Rice, 1996) . Like HIV-1, it is highly variable; HCV establishes a chronic infection in most hosts and so is subject to continuous immune pressure and rapid accumulation of mutations. The virus has been classified into six different genotypes, which have each been subdivided into a large number of subtypes. The Env E1 and E2 proteins of HCV form heterodimers on the virion surface, and glycosylation is essential for this dimerization (Meunier et al., 1999) . The variability of both proteins is comparable, from 88% nucleotide (90% amino acid) identity between strains from the same subtype to 55% nucleotide (59% amino acid) identity between different genotypes. In both E1 and E2, N-glycosylation sites are limited to the amino terminus of the proteins; the carboxy-terminal region of these proteins is the transmembrane portion. The efficient glycosylation of E1 is dependent on the presence of E2 in a polyprotein (Deleersnyder et al., 1997) , although it does not appear to depend on the specific sequence of E2 (Dubuisson et al., 2000) , and the noncovalent association of E1 and E2 depends on the first and fourth glycosylation sites of E1 (Meunier et al., 1999) . It has been shown that the glycans attached to the E1E2 heterodimer prior to budding of the virus are exclusively high-mannose (Deleersnyder et al., 1997) , although E1E2 found circulating on HCV virions also have complex carbohydrates (Sato et al., 1993) . As in HIV, sequon changes have been shown to change antibody exposure in HCV (Fournillier et al., 2001) .
In this study, we characterize patterns in viral glycosylation site variation at the population level for influenza, HIV, and HCV and describe a Web-based program that M. Zhang et al. was used to facilitate tracking sequons in protein alignments for these comparisons.
Results
Influenza proteins and N-linked glycosylation patterns over time Using alignments and sampling dates obtained from the 2003 Los Alamos Influenza Sequence Database (www.flu. lanl.gov), we confirm ( Figure 2A ) the H3 HA1 protein gradually increases in the median number of N-linked glycosylation sites over time (from 6 to 10), with a small amount of within-year variation. The acquisition of some of these sites can be directly related to antigenic drift (Skehel and Wiley, 2000) , the change in the antigenic profile of influenza from year to year that necessitates annual review and frequent updates of the vaccine strain.
However this net increase in the number of sequons is not a general feature of influenza evolution and is only found in the human H3 serotype of influenza A, not in other serotypes of influenza A (Figure 2 ), nor in the avian H3 over time, or in any other avian serotype with adequate sampling over time, nor in the human influenza B HA1 (Figure 2 , plus summary in legend). There was also no trend for increasing numbers of sequons over time in the avian or human neuraminidase (N2) serotype proteins, although this protein is also heavily glycosylated and shows variable numbers of sites from year to year ( Figure 2D ).
Global trends in glycosylation patterns in HIV Env
There is no net tendency for the sequon number to increase or decrease over time in the HIV-1 M group, or within subtypes or CRFs (Figure 3 ). Two kinds of sequons are evident in HIV-1 and HIV-2: those embedded in readily aligned positions and those embedded in hypervariable regions that shift in relative position and regional density by base mutation and by insertions and deletions. Here we refer to these two classes of sequons as fixed and shifting, respectively. Although most of the shifting sequons are found in variable loops, some are also present in the C4 region (conserved, or C, domains in the HIV envelope were called conserved because they are relatively conserved when compared to the variable regions, however, they can also span insertions and deletions that can result in shifting sequon locations). The location and frequency of sequons in gp120 in each major subtype of the HIV-1 M group (Gao et al., 1996; Robertson et al., 2000) are illustrated in Figure 4 . Despite the extreme variability between isolates, there is an essentially conserved pattern of variation in each of the HIV-1 M group subtypes, and even in the genetically very distant HIV-1 group O. (There are insufficient fulllength HIV-1 group N sequences for a comparison). Protein regions show the same frequencies for most sequons in each HIV-1 lineage and subtype, suggesting that selective pressures on sequons in these diverse lineages are consistent (Figure 4 ). HXB2 and SF2 are common HIV-1 reference strains for which the N-linked carbohydrates additions to Env gp120 have been biochemically defined (Leonard et al., 1990; Zhu et al., 2000) . We aligned the SF2 protein sequence to HXB2 strain and noted the types of carbohydrate found: mannose, complex carbohydrate, or a mixture of both (hybrid carbohydrates). We also found that different types of carbohydrates were associated with fixed and shifting sequons defined at the population level ( Figure 4 ). There are 24 N-linked glycosylation sites in HXB2, and 26 in SF2, and they differ in location in seven cases. In HXB2, all seven shifting sequons in Env gp120 are complex carbohydrates (7/13 complex carbohydrate additions, 54% are in the shifting regions), whereas all high-mannose or hybrid carbohydrates are in fixed positions (11/11, 100%, Fisher's exact test p-value ¼ 0.006). When an additional sequon in the shifting V1 region of the HXB2-related variant LAI was later characterized, it also carried a complex carbohydrate (Gram et al., 2002) , consistent with this pattern. For SF2, some of the sequon positions contained hybrid carbohydrates, and some were only partially glycosylated. Though the high-mannose residues were not significantly correlated the fixed sequons of SF2, the trend from HXB2 was evident: 8/11 (72%) of high mannose glycosylation sites were in fixed sequons, whereas 8/14 (57%) complex carbohydrates were in shifting sequons, and one was unknown. A structural model of the fully glycosylated SF2 gp120 suggests that the high-mannose glycans are clustered on one surface of the protein and the complex carbohydrates are localized on distinct region of the protein surface (Zhu et al., 2000) .
The 2G12 monoclonal antibody is one of the few broadly cross-reactive human HIV-neutralizing antibodies, and it has an unusual epitope involving several mannose carbohydrates that project from the generally immunorefractive glycosylated face of HIV-1 Env. Not surprisingly, crosscompetition studies have shown that B cell responses to 2G12 epitope are very unusual in HIV-1-infected individuals (Moore and Sodroski, 1996) . The sites that comprise the epitope, indicated in Figure 4 , require mannose at positions of N295, N332, and N392 for 2G12 binding (Sanders et al., 2002; Scanlan et al., 2002) . (See the HXB2 sequence locator tool in the HIV database [www.hiv.lanl.gov] to determine the specific positions referred to in this text.) These sites are well conserved in most subtypes, and tend to show comparable levels of glycosylation. The exception is subtype C, which only rarely has a glycosylation site immediately next to the Cys at the base of the V3 loop (N295). It has been suggested that the 2G12 epitope may be conserved because its structure enhances gp120-mannose interactions with the human protein dendritic cell-specific HIV-1-binding protein (DC-SIGN), an interaction that faciliatates efficient HIV-1 infection (Sanders et al., 2002) .
The global collection of HIV Env gp120 molecules shows small but significant variations in the distributions of sequon frequencies for each subtype (Kruskal-Wallis p-value ¼ 0.0002). Occasionally a site will be completely lost or added in a subtype (Figure 4 ), like the loss of a shifting sequon in CRF01 (subtype E in Env) in the V4 region or the additional N-terminal fixed site in O group. These differences may simply reflect a founder effect in the lineage, or may confer a critical change to the conformation of Env in the context of a particular lineage. Although the sequon frequencies in different HIV-1 subtypes are N-linked glycosylation site variation in viral proteins significantly different, perhaps more important are the similarities between subtypes: The range of sequon frequencies is broad and basically overlapping within all subtypes (Gao et al., 1996) (Figure 5 ), and the conserved sites as well as frequencies of variable sites tend to be comparable between subtypes (Figure 4) . N-linked glycosylation patterns related to coreceptor usage and phenotype HIV-1 Env enters CD4-positive T cells through a series of steps involving binding to both the CD4 protein and a chemokine receptor protein, usually CCR5 (R5 viruses) or CXCR4 (X4 viruses); some viruses can use either chemokine receptor (R5X4 viruses) (Cho et al., 1998) . Sets of Env protein sequences derived from R5, X4, or R5X4 viruses were obtained from in the Los Alamos HIV database (www.hiv.lanl.gov). The total number of sequons in gp120, and in subregions of gp120 including the variable domains V1 and V2, which play a role in coreceptor usage in certain contexts (Cho et al., 1998; Hoffman et al., 1998; Pollakis et al., 2001) , were nearly identical among R5, X4, and R5X4 viruses. However, two sequons in fixed sites show distinctive frequencies ( Figure 6 ). The most striking was the sequon located within the V3 loop at position N300 of HXB2, which was present in all 44 R5 isolates (100%), but only in 4/11 (36%) X4 isolates and 7/11 (64%) R5X4 isolates (Fisher's exact test p-value ¼ 4 Â 10 À7 ). Site-directed mutagenesis has shown this site to be associated with coreceptor usage (Ogert et al., 2001; Pollakis et al., 2001) . The other potentially interesting site was at position N230 of HXB2, which was less common in the CCR5-utilizing group relative to the CXCR4 and R5X4 viruses, although this difference was just a trend and not statistically significant (11/44 [25%] had the site among R5 viruses, versus 6/11 [55%] in X4, and 5/11 [45%] in R5X4). 
N-linked glycosylation site variation in viral proteins
A virus's ability to form multinucleated syncytia in indicator cell lines distinguishes R5 and X4 viruses. Viruses isolated from newly infected people tend to be nonsyncytium-inducing (NSI) and R5, whereas X4 and syncytium-inducing (SI) viruses tend to appear later in infection, and the SI/NSI designations are available for many viral sequences that do not have defined coreceptor usage. So to further compare the glycosylation patterns Fig. 4 . Frequency of N-linked glycosylation sites in HIV Env gp120 based on an alignment of HIV-1 M group subtypes and circulating recombinant forms. Sequons in HIV-1 subtypes and CRFs with the most available full-length gp120 sequences are shown here. The sequences were aligned, and the fraction of sequons in every position in the alignment of each subtype is indicated. The sequons we refer to as shifting are highlighted in gray. The alignment is numbered according to positions in the HXB2 reference strain. The sequons in particularly positions in two HIV-1 reference strains are indicated, HXB2 and SF2. The biochemistry of the oligosaccharide additions has been determined for these two strains (Leonard et al., 1990; Zhu et al., 2000) , and high mannose is indicated at the top of appropriate sequons with an M, complex carbohydrates are labeled under each sequon with a C. Some mixtures of both were identified in SF2 (Zhu et al., 2000) . The locations of variable loops in gp120 are indicated in black box on the reference strains. The high-mannose carbohydrates critical for 2G12 binding are indicated (Sanders et al., 2002; Scanlan et al., 2002) .
with viral phenotypes, we analyzed the number and position of sequons in full length Env, including gp41 (Figure 7) as well as gp120, from SI and NSI patients. Two significant changes were observed: One was the loss of a sequon at position N136 in SI viruses, located in the V1 loop, and the other was a gain of a sequon in gp41 at position N674.
We then determined if the sequon alterations associated with phenotypic change at the population level are mirrored in an individual patient (Hu et al., 2000) . In the patient studied, there was a one-to-one correspondence between NSI and R5 usage and SI and X4 usage. All significant changes of sequons were found in regions V1, V2, V4, and V5, primarily in the N-terminal regions of V1 and V4. In gp120, there are 19 highly conserved sites, 4 additional sequons from NSI to SI, and 5 losses from NSI to SI. Three of these changes were in shifting sites, simply moving the sequon by one position relative to context of the protein (in V1, N136 to N136þ, N141 to N142, and in V4, N401 to N402). The NSI-to-SI phenotypic switch was accompanied by these three shifts in sequon position, a loss of sequon N188 in V2 and N405 in V4, and a gain of a sequon at position N463 in V5. In this patient, the sequon at position N300 was unchanged and not related to coreceptor usage, and gp41 sequons were invariant, emphasizing that there are exceptions to the statistical correlations that can be detected at the population level.
N-linked glycosylation patterns in other primate lentiviruses Among the primate lentiviruses, Env sequon variation in M group viruses is the most extreme relative to the genetic distances based on base substitution (Wills et al., 1996) . However, SIVs do vary extensively and also show some interesting glycosylation patterns (Chackerian et al., 1997; Nyambi et al., 1997; Overbaugh and Rudensey, 1992) . Using phylogenetic analysis, we selected HIV-2 and SIV sequences representing the spectrum of natural diversity in each lineage. Shifting sites, analogous to those found in HIV-1, were apparent in HIV-2 and in chimpanzee viral Envs (SIV CPZ ). The human HIV-1 epidemic is thought to have resulted from a cross-species transmission from chimpanzee, whereas human HIV-2 and macaque SIV MAC result from cross-species transmission of SIV SMM virus from the sooty mangabey, its natural host (Gao et al., 1996; Hirsch et al., 1989) . In SIV SMM and African green monkey SIV AGM , shifting sites tended to resolve into fixed sites ( Figure 8A) , with the exception of the V4 region in SIV AGM . Table I highlights the sequons in the V1 loops from sequences used to generate the frequencies shown in Figure 8 . Although there was length variation in SIV SMM and SIV AGM V1 sequences, the relative placement of the sequons and the Cys involved in the disulfide bridge that forms the base of the loop was conserved (Table I ). In contrast, shifting sequons are frequently seen in infected macaques (SIV MAC ) followed over time through progression to simian AIDS (Chackerian et al., 1994 (Chackerian et al., , 1997 Overbaugh et al., 1991) and in HIV-2 sequences in human ( Figure 8A , Table I ). Because HIV-2 and SIV MAC infections result from cross-species transmission of SIV SMM virus from sooty mangabeys (Gao et al., 1996; Hirsch et al., 1989) , the degree of variation in shifting sites is host-specific for viruses of this lineage. SIV SMM does not cause disease in sooty mangabeys, but it does in macaques, as does HIV-2 in humans. Like SIV SMM , SIV AGM does not cause disease in its natural host species, African green monkeys, and is readily found in animals in the wild (Norley et al., 1999; Ohta et al., 1988) .
HCV E1 and E2 protein N-linked glycosylation site patterns
The sequons in HCV Env E1 and E2 proteins are far less variable in HIV-1 envelopes, despite HCV otherwise being an extraordinarily variable virus. After creating alignments of the available HCV E1 and E2 sequences in GenBank, the sequences were checked by phylogenetic analysis, and very similar sequences were removed, leaving 294 distinct E1 protein sequences and 130 E2 sequences for comparisons. Numbering of the E1 and E2 positions in this section is based on the Los Alamos Hepatitis C Database HCV Sequence Locator tool (http://hcv.lanl.gov/content/ hcv-db/LOCATE/locate.html).
There are typically 5-7 sequons in E1 over a stretch of 194 amino acids. Four of these sites are highly conserved among all genotypes. The site at position N61 in the alignment was present in genotype 6 and 1b but absent in all other genotypes (Figure 9, top) . A pair of adjacent sequons at positions N43/N44 also showed subtype-specific variation, the site at position N43 being present in subtype 2b, and the one at N44 in 2a and 2c, as well as in most other sequences. In 35% of the subtype 1b sequences, the N43 and N44 sites were both present; this occurred in 1 sequence of another genotype, a 3b. The sequences with two sequons did not 
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appear to come from a specific geographic region and probably arose independently. The sequons at positions N5 and N136 of E1 have been shown to be essential for formation of E1-E2 complexes on the virion surface (Meunier et al., 1999) ; N136 also is important in reducing the antigenicity of the virus (Fournillier et al., 2001) . Little is known about genotype-or subtype-specific differences in viral phenotype. Sequons in the E2 protein were mostly limited to the N-terminal part of the protein, with 10-11 sites all located before amino acid 272 (the total length of the E2 alignment was 436 amino acids). Some type-specific sequon patterns were also found in E2, as all sequences of genotypes 3 and 6 missed the site at position N160. Only one or two sequences of genotypes 4 and 5 were available, so variation analysis was not possible for these genotypes. Within genotype 1, the sequon at position N94 was highly conserved in subtype 1a but present in only 17/101 sequences of subtype 1b. This site was one of the two sequons in E2 that shifted in terms of its relative position, that is, it could be found starting anywhere between positions 92 and 95 (Figure 9 , bottom), suggesting that either there is pressure for this subtype to incorporate a glycosylation site in this region of the protein or that there is a selective advantage in retaining the site in the region but modifying its precise location. Another shifting site was found in E2, specifically in genotype 6. This site was embedded in the only region with multiple insertions and deletions in HCV, and it shifts relative location on the basis of insertions and deletions, and is lost in one of the sequences (Figure 9, bottom) . The presence of shifting glycosylation sites in the E2 protein, like HIV-1 Env, is probably related to its profound immunogenicity and escape-related variability.
Discussion
The potential of changing N-linked glycosylation sites as a mechanism for immune evasion has long been appreciated (Alexander and Elder, 1984) . In influenza, the steady increase in the number of sequons in H3 HA1 over time (Skehel and Wiley, 2000) is the exception, as the number of sequons in human H1 HA1 and neuraminidase N2 proteins oscillates but does not show a net increase. The sequon frequency in avian influenza hemagglutinin proteins oscillates at roughly comparable levels to the human proteins, despite having a very different ecology: In aquatic avian species flu is asymptomatic, and the viruses are in evolutionary stasis (Webby and Webster, 2001) , whereas in human epidemics, the virus causes disease and generates new variants that are able to infect hosts who have become immune to earlier influenza strains (Bush et al., 1999; Ferguson et al., 2003) . It seems possible that the increase in sequon frequency in H3 HA1 in humans is a local fluctuation over time, and it too will move to random oscillation in future years. Although year of sampling was not readily available for the HCV sequences, HCV shows much less variation in sequons, and this variation seems to be due to lineage-specific patterns that would be unlikely to vary by sampling year.
There is a striking recapitulation of sequon patterns in different levels of HIV evolution. The level of sequon variation that can be seen in an individual is mirrored at the level of variation seen within a subtype, which is further reflected at the level of variation seen within the HIV-1 M group global epidemic. Thus the boundaries of the potential to add and eliminate sequons to facilitate immune escape and infect a range of cell types, within what is tolerated in terms of fitness costs, may be explored anew during the course of each HIV-1 infection of a single individual. Although the phylogenetic tree of HIV-1 is clearly expanding over the time period during which we have followed HIV-1 in the human population (Korber et al., 2000; Robbins et al., 2003; Yusim et al., 2001) , the sequon variations in gp120 and gp41 seem instead to be rapidly fluctuating within inherent boundaries.
There is probably an upper bound to the number of sequons that can be maintained on Env gp120, because carbohydrate structures are quite large and their presence or absence must influence the protein's conformation. For example, there are two sequons next to cysteines that form the base of the V3 loop. A typical glycan is about 2000 Da, and the V3 loop is only about 3000 Da, so the presence or absence of these sequons would logically impact the orientation with which the V3 loop projects from the protein surface. Glycosylation sites may be preserved in vivo to mask neutralizing antibody sites, but replication efficiency and access to receptor binding sites may provide a counterbalancing force-multiple glycosylation sites can be removed from gp120 without loss of infectivity (Ohgimoto et al., 1998) .
The observation that the complex carbohydrates tend to be localized in the shifting positions while high mannose is Fig. 7 . N-linked glycosylation site changes in Env gp41 in NSI isolates and SI isolates from patients infected with HIV-1 subtype B. HIV-1 B gp41 sequences were aligned and analyzed for sequon differences between 21 NSI and 17 SI sequences. Protein sequences were obtained from the HIV database; only one sequence per patient was used. Sequences were analyzed for patterns of glycosylation using the LANL N-glycosite program (http://hiv-web.lanl.gov/content/hiv-db/ GLYCOSITE/glycosite.html).
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favored in the fixed positions in HIV-1 Env gp120 could result from multiple contributing factors. The interactions of DC-SIGN and other C-type lectins with gp120 highmannose oligosaccharides have an important role in HIV infectivity (Lin et al., 2003) , suggesting there may be a fitness cost in disrupting their precise orientation. If the high-mannose oligosaccharides are important for successful sexual transmission, there would be selection pressure to Although only limited numbers of complete gp120s that represent distinct lineages of SIV SMM and SIV AGM are available, the shifting sites are not readily apparent in these viruses when infecting their natural hosts. Two exceptions are that shifting sequons are not evident V4 in the HIV-2, and are indicated in the SIV AGM set. (B) Phylip PROTDIST tree of gp120 sequences (http://evolution.genetics. washington.edu/phylip.html) used for the analysis shown in A. This tree is simply meant to illustrate the extent of diversity in the population of protein sequences of these viruses in different hosts. Most of the specific sequences used to generate A and B of this figure are listed in Figure 4 , although only a subset of the HIV-2 sequences are included in Table I to save space (18 are included here).
M. Zhang et al. Spacing of sequons in V1 loops N-linked glycosylation site variation in viral proteins preserve the high-mannose forms. It has been suggested that the conservation of the high-mannose epitope for the 2G12 antibody might be related to the preservation of mannose structure that facilitates DC-SIGN interaction (Sanders et al., 2002) . N-linked glycosylation patterns in HIV Env are further complicated by the fact that different cell types, H9 and Chinese hamster ovary (Mizuochi et al., 1988 (Mizuochi et al., , 1990 , and primary T cells and macrophages have different patterns of glycan modification (Liedtke et al., 1997; Lin et al., 2003; Willey et al., 1996) . DC-SIGN preferentially binds to HIV Env gp120 enriched for highmannose oligosaccharides, which are typically produced Only N-linked glycosylation sites (N) and Cys (C), which close the base of the V1 loop, are marked, all other amino acids are indicated by a period (.), to highlight the relative change of position of the N-linked sites and the length variation of the V1 loop. Parts C-G correspond to the sequences used in Figure 8A . Part A includes examples of V1 sequences taken from a single patient over time in a study of long-term survival (patient 20 from Shioda et al., 1997) , who was randomly selected from among longitudinal sequences sets spanning V1 available in the HIV database, and in our experience is representative. Part B includes seven randomly selected subtype A sequences from the HIV Los Alamos database alignment to represent intraclade diversity, respectively. Part C includes one randomly selected sequence from each clade to represent HIV-1 M group diversity. Part D includes available viral sequences isolated from chimpanzees, thought to be the source of the human HIV-1 epidemic. Part E lists viruses from HIV-2 clades A and B, and part F from sooty mangabey, which are thought to be the source of the HIV-1 epitdemic. Part G represents viral sequences taken from African green monkeys.
M. Zhang et al. by peripheral blood mononuclear cells and T cells, compared to macrophage-produced gp120, which contains more complex carbohydrates (Lin et al., 2003) . Also, macrophage-derived gp120 carbohydrates are modified by lactosaminoglycans, whereas peripheral blood mononuclear cells-derived gp120s are not. Interestingly, macrophage-derived virus tends to be more neutralization resistant (Willey et al., 1996) . Bisecting N-glycans have been implicated in the suppression of natural killer (NK) cell-mediated responses (Yoshimura et al., 1996) , the suppression of innate immune responses involving NK cells that may be responsible for initiating AIDS pathogenesis (Kottilil et al., 2003) . Thus cell-specific glycosylation profiles may affect immune susceptibility, and AIDS progression may be related to the glycobiology of the virus (Clark et al., 1997) . . The most C-terminal sequon in E1 is not glycosylated, and the sequon second from the C-terminal end and the most N-terminal together are critical for the formation of noncovalent E1E2 complexes (Meunier et al., 1999) .
Positions that accept complex carbohydrate additions may also be determined simply by being more exposed during passage through the Golgi apparatus, where carbohydrate modifications occur. Such exposure may be related to accessibility in the folded functional protein, and immune evasion and neutralizing antibody escape are likely to be the driving force for the variation in shifting sites. So the complex carbohydrate additions may occur in more exposed sites, and those sites, due to the exposure, may be under greater pressure to shift to escape from antibody recognition.
We did not observe variation in the net number of sequons in the variable loop domains of HIV-1 Env gp120 associated with any particular pattern of coreceptor usage, although a particular sequon in the V3 loop was highly conserved in R5 viruses but not in X4 or R5X4 viruses. Potential involvement of sequon changes in gp41 in cell tropism was also noted, as some sites are rarely found in NSI variants. Glycosylation in gp41 may be more influential than previously thought, given new evidence that additional loops of the transmembrane protein are located extracellularly (Cleveland et al., 2003) . The role of alterations of specific sequons in HIV-1 Env associated with changes in coreceptor usage on a population basis can be subtle and may be context-specific. For example, in our analysis of one patient for changes associated with phenotypic variation (Figure 7 ), significant differences were found at positions that were different from those identified in the cross-sectional population analyses.
Glycosylation in the V1V2 region can be important for coreceptor usage (Ogert et al., 2001) , and additional glycosylation sites in V1V2 may in some circumstances potentiate the use of CXCR4 (Pollakis et al., 2001) . V2 elongation and sequon changes have been associated with slow disease progression (Shioda et al., 1997) . The effects may be subtle; for example, removal of three sequons in V1 increased the affinity between gp120 and the CXCR4 receptor but did not alter the infectivity of the virus (Losman et al., 2001) . Limited V1V2 length variation and sequon shifts in rapid progressors (Masciotra et al., 2002; Shioda et al., 1997) versus long-term survivors may be a consequence of a poor immune response resulting in weak selection pressure (Delwart et al., 1997; Wolinsky et al., 1996) and not related directly to the coreceptor usage. This is particularly plausible because changes in V1 V2 sequons often influence antigenic domains in other regions, for example, they can alter antibody recognition of both the V3 loop (Losman et al., 2001; Ly and Stamatatos, 2000; Ye et al., 2000) and CD4 binding site (Ly and Stamatatos, 2000) . It is intriguing that the capacity for shifting sequons is found not only in HIV but also in two HCV E2 locations in two lineages in genotypes 1 and 6, suggesting they may give a selective advantage in rapidly evolving viruses.
Although the SIV SMM and SIV AGM viruses have some degree of shifting sequons in their natural hosts (particularly in the Env V4 region in SIV AGM ), the shifting Env sequon characteristics appear far less pronounced in these lineages than in HIV-1 and CPZ lineages (Figure 8 ). HIV-2, which stems from cross-species transmission of SIV SMM , also has more extreme levels of shifting sites, suggesting that selective forces in the new host bring out the greater levels of position diversity seen in sequons. Neutralizing antibody responses to SIV SMM and SIV AGM infections in their natural hosts are present but may be relatively reduced (Fultz et al., 1990; Gicheru et al., 1999; Kaur et al., 1998; Norley et al., 1990) . However, despite the lack of shifting sequons, both SIV SMM and SIV AGM diversify rapidly in vivo (Broussard et al., 2001) . At least some of this diversification may be due to cytotoxic T lymphocyte escape (Kaur et al., 2001 ), which may not select for patterns of shifting sequons. Neutralizing activity of sera from HIV-infected individuals and SIV-infected primates generally lags behind, so serum from one time point can neutralize earlier but not contemporary virus (Albert et al., 1990; Arendrup et al., 1992; Bradney et al., 1999; Montefiori et al., 1991; Nyambi et al., 1997) . Rapid cycles of response and escape may be related to the gain and loss of sequons (Richman et al., 2003; Wei et al., 2003) . Thus it is possible that the strength and neutralizing antibody response in the host dictates the extent of the shifting antibody sites in different primate lentiviruses.
N-linked glycosylation sites are a critical component of the external proteins of primate lentiviruses, influenza, and hepatitis C viruses, and their modification can be important for evolution of the immune response. The gain or loss of such sites can play a key role in viral infectivity, antigen conformation, and immune escape. The mechanisms that generate shifting sites and tolerance of such shifting sequons in viral proteins provides a unique evolutionary avenue for immune evasion.
Materials and methods
A Web-based tool was developed for tracking and quickly assessing patterns in N-linked glycosylation sites in protein alignments (www.hiv.lanl.gov/content/hiv-db/GLYCOSITE/ glycosite.html). This facilitates comparing glycosylation patterns by providing five different summaries: i. A simple tally of the number of sequons in each protein in an alignment; ii. Red highlighted N-linked glycosylation sites in the alignment, and a downloadable fasta-format text file that leaves the N in sequons uppercase while reducing all other amino acids to lowercase; iii. Plots of the fraction of sequences in each alignment that carry an N-linked glycosylation site at each position; iv. A summary of the average number of sites within a user-specified window size, and a break down for each sequence; v. A list of sequons and their context in each sequence, providing the amino acid string of the sequons, as not all sequons have the same capacity to be glycosylated (for example, N-P-[ST] is not glycosylated), and such sites were not observed among the viral sequences studied here. We also include links to references defining glycosylation propensities of different local combinations of amino acids.
All features of the program were used to analyze the sequence sets included in this study, but most of the figures were made using feature iii.
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The protein alignments used for this study were retrieved from the Los Alamos HIV sequence database (www.hiv.lanl.gov), Influenza database (www.flu.lanl.gov), and the Hepatitis C database (www.hcv.lanl.gov). All alignments used in this study are available on request. All hepatitis, SIV, and HIV alignments were restricted so that only sequence from a single individual was included. Thus the sample sets were not biased by including multiple sequences from one person or from closely related infections. The one exception is the sequon change analysis of single patient in Figure 7 (Hu et al., 2000) .
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